Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins

Journal of Virology

Volumn 75, Issue 24, 2001, Pages 12121-12127

  Satoi, J ^a   Murata, K ^a   Lechmann, M ^a   Manickan, E ^a   Zhang, Z ^a   Wedemeyer, H ^a   Rehermann, B ^a   Liang, T J ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; HLA A2 ANTIGEN; PHCVST; PLASMID DNA; RECOMBINANT PROTEIN; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS PROTEIN;

ADOPTIVE TRANSFER; ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; HEPATITIS C VIRUS; HISTOPATHOLOGY; HLA TYPING; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN STRUCTURE; STRAIN DIFFERENCE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; VIRUS MORPHOLOGY;

ADOPTIVE TRANSFER; ANIMALS; FEMALE; HEPACIVIRUS; HEPATITIS C ANTIBODIES; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA; VIRAL CORE PROTEINS; VIRAL ENVELOPE PROTEINS; VIRAL HEPATITIS VACCINES;

EID: 0035202920     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.24.12121-12127.2001     Document Type: Article

References (39)

1. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo
2. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.I molecules
3. Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate
4. Peripheral deletion of autoreactive CDS+ T cells in transgenic mice expressing H-2Kb in the liver
5. T-cell tolerance by clonal anergy in transgenic mice with nonlymphoid expression of MHC class II I-E
6. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses
7. Analysis of a successful immune response against hepatitis C virus
8. High prevalence of hypervariable region 1-specific and-cross-reactive CD4(+) T cells in HCV-infected individuals responsive to IFN-alpha treatment
9. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization
10. Organ injury associated with extrathymic induction of immune tolerance in doubly transgenic mice
11. DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface
12. Expression of noncovalent hepatitis C virus envelope E1-E2 complexes is not required for the induction of antibodies with neutralizing properties following DNA immunization
13. Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells
14. Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization
15. T cell memory. Long-term persistence of virus-specific cytotoxic T cells
16. Transgenic expression of hepatitis C virus structural proteins in the mouse
17. An efficient expression vector for stable expression in human liver cells
18. Genetic control of the cytotoxic T cell response to SV40 tumor-associated specific antigen
19. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV
20. CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose
21. Hepatitis C virus-like particles induce virus-specific humoral and cellular immune responses in mice
22. Optimal induction of hepatitis C virus envelope-specific immunity by bicistronic plasmid DNA inoculation with the granulocyte-macrophage colony-stimulating factor gene
23. Failure to induce organ-specific autoimmunity by breaking of tolerance: Importance of the microenvironment
24. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state
25. Immunology of the healthy liver: Old questions and new insights
26. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C
27. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice
28. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response
29. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection
30. Plasmid DNA-based immunization for hepatitis C virus structural proteins: Immune responses in mice
31. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice
32. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1
33. Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity
34. Homeostasis and self-tolerance in the immune system: Turning lymphocytes off
35. Break of T cell ignorance to a viral antigen in the liver induces hepatitis
36. Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity
37. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice
38. Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV
39. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses